Withdrawal of Offering Statement Under Regulation a (1-a-w)
10 Januar 2020 - 12:52PM
Edgar (US Regulatory)
AMARANTUS
BIOSCIENCE HOLDINGS, INC.
January
9, 2020
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F. Street, N.E.
Washington,
D.C. 20549
Re:
|
Amarantus Bioscience Holdings, Inc.
|
|
Request for Withdrawal of Offering Statement on Form 1-A
|
|
Submitted January 9, 2020
|
|
File No. 024-11138
|
Ladies
and Gentlemen:
Amarantus Bioscience Holdings, Inc. (Applicant), hereby applies for the Commission’s consent to withdraw its Offering
Statement dated January 9, 2020, file number 024-11138.
The
Offering Statement was submitted as a new Form 1-A instead of a Form 1-A/A to a previous offering that was originally
filed with the SEC on September 27, 2019. The correct Offering Statement was resubmitted under
Form 1-A/A.
Applicant has
not sold any securities pursuant to the Offering Statement submitted on January 9, 2020.
If
you have any questions or comments regarding these responses or require any additional information, please do not hesitate to
contact me or my counsel, Eilers Law Group, P.A. at (786) 273-9152.
|
Very
truly yours,
|
|
|
|
/s/ Gerald
Commissiong
|
|
Gerald
Commissiong
|
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
Echtzeit-Nachrichten über Amarantus Bioscience Holdings Inc (CE) (OTCMarkets): 0 Nachrichtenartikel
Weitere Amarantus Bioscience Holdings, Inc. News-Artikel